Could a puff of inhaled insulin stop Exercise-Induced lows in type 1 diabetes?

NCT ID NCT06880835

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times

Summary

This study looks at whether inhaled insulin (Afrezza) is safer than pump insulin for preventing low blood sugar during exercise after a meal in adults with type 1 diabetes. About 30 people aged 18-65 who use a Tandem insulin pump with Control-IQ will complete three exercise sessions in a clinic. The goal is to see if the inhaled insulin leads to fewer blood sugar drops below 70 mg/dL within 90 minutes of starting exercise.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Louisville

    RECRUITING

    Louisville, Kentucky, 40202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Washington

    RECRUITING

    Seattle, Washington, 98195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.